Gonal-f RFF redi-ject 900 unit 1.44ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM2JG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,263
Award facts
- Contract value 100% obligated
- $46,263.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,263.20 to AmerisourceBergen Drug Corp for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.44ML, a pharmaceutical product used in fertility treatment. Issued on January 13, 2026, with an ultimate completion date of January 14, 2026, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including military and veteran medical programs.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The DLA Troop Support Medical is strategically planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with anticipated multiple awards across separate regions, demonstrating the agency's commitment to maintaining robust pharmaceutical supply capabilities for the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FM2JG?
SPE2DR26FM2JG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FM2JG worth?
The government has obligated $46,263 on SPE2DR26FM2JG.
Is contract SPE2DR26FM2JG an order under another contract?
Yes. SPE2DR26FM2JG is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM2JG competed?
The extent of competition for SPE2DR26FM2JG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award